Anna L. Barry
PH.D., J.D.
immunology
Pfizer
Japan
Biography
Dr. Barry brings to Jounce more than 15 years of intellectual property, corporate and transactional legal experience in the biotechnology industry. Prior to joining Jounce Therapeutics, Dr. Barry was senior intellectual property counsel at Five Prime Therapeutics, where she managed all aspects of intellectual property related to the company’s therapeutic pipeline and platform technology. Prior to joining Five Prime Therapeutics, Dr. Barry served as senior patent counsel at Genentech, where she managed oncology and metabolism patent portfolios. Before Genentech, Dr. Barry was an attorney at Heller Ehrman LLP, where her practice focused on counseling life sciences and biotechnology companies.
Research Interest
Dr. Barry was senior intellectual property counsel at Five Prime Therapeutics, where she managed all aspects of intellectual property related to the company’s therapeutic pipeline and platform technology. Prior to joining Five Prime Therapeutics, Dr. Barry served as senior patent counsel at Genentech, where she managed oncology and metabolism patent portfolios. Before Genentech, Dr. Barry was an attorney at Heller Ehrman LLP, where her practice focused on counseling life sciences and biotechnology companies.
